BNTX
Price
$103.89
Change
-$7.81 (-6.99%)
Updated
Nov 13, 04:59 PM (EDT)
Capitalization
26.86B
117 days until earnings call
Intraday BUY SELL Signals
KYMR
Price
$63.61
Change
+$0.08 (+0.13%)
Updated
Nov 13, 04:59 PM (EDT)
Capitalization
4.57B
98 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

BNTX vs KYMR

Header iconBNTX vs KYMR Comparison
Open Charts BNTX vs KYMRBanner chart's image
BioNTech SE American Depositary Share
Price$103.89
Change-$7.81 (-6.99%)
Volume$18.33K
Capitalization26.86B
Kymera Therapeutics
Price$63.61
Change+$0.08 (+0.13%)
Volume$18.72K
Capitalization4.57B
BNTX vs KYMR Comparison Chart in %
View a ticker or compare two or three
VS
BNTX vs. KYMR commentary
Nov 14, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BNTX is a Hold and KYMR is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Nov 14, 2025
Stock price -- (BNTX: $111.70 vs. KYMR: $63.53)
Brand notoriety: BNTX and KYMR are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BNTX: 127% vs. KYMR: 115%
Market capitalization -- BNTX: $26.86B vs. KYMR: $4.57B
BNTX [@Biotechnology] is valued at $26.86B. KYMR’s [@Biotechnology] market capitalization is $4.57B. The market cap for tickers in the [@Biotechnology] industry ranges from $110.16B to $0. The average market capitalization across the [@Biotechnology] industry is $2.1B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BNTX’s FA Score shows that 1 FA rating(s) are green whileKYMR’s FA Score has 0 green FA rating(s).

  • BNTX’s FA Score: 1 green, 4 red.
  • KYMR’s FA Score: 0 green, 5 red.
According to our system of comparison, BNTX is a better buy in the long-term than KYMR.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BNTX’s TA Score shows that 6 TA indicator(s) are bullish while KYMR’s TA Score has 3 bullish TA indicator(s).

  • BNTX’s TA Score: 6 bullish, 4 bearish.
  • KYMR’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, BNTX is a better buy in the short-term than KYMR.

Price Growth

BNTX (@Biotechnology) experienced а +8.00% price change this week, while KYMR (@Biotechnology) price change was +6.08% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.51%. For the same industry, the average monthly price growth was -3.12%, and the average quarterly price growth was +61.90%.

Reported Earning Dates

BNTX is expected to report earnings on Mar 10, 2026.

KYMR is expected to report earnings on Feb 19, 2026.

Industries' Descriptions

@Biotechnology (+1.51% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BNTX($26.9B) has a higher market cap than KYMR($4.57B). KYMR YTD gains are higher at: 57.917 vs. BNTX (-1.975). BNTX has higher annual earnings (EBITDA): -72.1M vs. KYMR (-267.03M). BNTX has more cash in the bank: 14B vs. KYMR (665M). KYMR has less debt than BNTX: KYMR (85.7M) vs BNTX (270M). BNTX has higher revenues than KYMR: BNTX (2.88B) vs KYMR (44.7M).
BNTXKYMRBNTX / KYMR
Capitalization26.9B4.57B588%
EBITDA-72.1M-267.03M27%
Gain YTD-1.97557.917-3%
P/E Ratio161.76N/A-
Revenue2.88B44.7M6,438%
Total Cash14B665M2,105%
Total Debt270M85.7M315%
FUNDAMENTALS RATINGS
BNTX: Fundamental Ratings
BNTX
OUTLOOK RATING
1..100
80
VALUATION
overvalued / fair valued / undervalued
1..100
79
Overvalued
PROFIT vs RISK RATING
1..100
94
SMR RATING
1..100
91
PRICE GROWTH RATING
1..100
51
P/E GROWTH RATING
1..100
1
SEASONALITY SCORE
1..100
36

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
BNTXKYMR
RSI
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 2 days ago
89%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
79%
Bearish Trend 2 days ago
70%
Momentum
ODDS (%)
Bullish Trend 2 days ago
67%
Bullish Trend 2 days ago
84%
MACD
ODDS (%)
Bullish Trend 2 days ago
68%
Bearish Trend 2 days ago
89%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
70%
Bullish Trend 2 days ago
80%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
70%
Bullish Trend 2 days ago
80%
Advances
ODDS (%)
Bullish Trend 2 days ago
72%
Bullish Trend 2 days ago
84%
Declines
ODDS (%)
Bearish Trend 7 days ago
80%
Bearish Trend 23 days ago
87%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 2 days ago
88%
Aroon
ODDS (%)
Bullish Trend 2 days ago
62%
Bullish Trend 2 days ago
80%
View a ticker or compare two or three
Interact to see
Advertisement
BNTX
Daily Signal:
Gain/Loss:
KYMR
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
RAGHX29.320.30
+1.03%
Virtus KAR Health Sciences A
MEIAX52.820.21
+0.40%
MFS Value A
LBFIX60.36-0.05
-0.08%
ClearBridge Select I
JMNSX16.04-0.02
-0.12%
JPMorgan Research Market Neutral I
WRGCX21.90-0.03
-0.14%
Macquarie Small Cap Growth C

BNTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, BNTX has been loosely correlated with MRNA. These tickers have moved in lockstep 54% of the time. This A.I.-generated data suggests there is some statistical probability that if BNTX jumps, then MRNA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BNTX
1D Price
Change %
BNTX100%
+2.81%
MRNA - BNTX
54%
Loosely correlated
+1.14%
SMMT - BNTX
51%
Loosely correlated
-1.72%
KYMR - BNTX
46%
Loosely correlated
+0.25%
TIL - BNTX
45%
Loosely correlated
-4.83%
NVAX - BNTX
44%
Loosely correlated
-3.23%
More

KYMR and

Correlation & Price change

A.I.dvisor indicates that over the last year, KYMR has been loosely correlated with NRIX. These tickers have moved in lockstep 64% of the time. This A.I.-generated data suggests there is some statistical probability that if KYMR jumps, then NRIX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KYMR
1D Price
Change %
KYMR100%
+0.25%
NRIX - KYMR
64%
Loosely correlated
-5.37%
VERA - KYMR
60%
Loosely correlated
+4.61%
NUVL - KYMR
55%
Loosely correlated
+0.91%
CGON - KYMR
54%
Loosely correlated
+1.47%
IDYA - KYMR
54%
Loosely correlated
-0.19%
More